Literature DB >> 2900537

Glutamate transmission and toxicity in Alzheimer's disease.

J T Greenamyre1, W F Maragos, R L Albin, J B Penney, A B Young.   

Abstract

1. Despite intensive research, the cause of Alzheimer's disease is unknown. 2. Glutamate is the major excitatory transmitter of the cerebral cortex and hippocampus and it appears to have an important role in learning and memory. In addition to its transmitter function, glutamate is a neurotoxin which has been implicated in the pathogenesis of a variety of neurodegenerative disorders. 3. Glutamate toxicity may play a role in the pathogenesis of Alzheimer's disease. 4. Disruption of glutamatergic neurotransmission may account, in part, for the learning and memory deficits of Alzheimer's disease. 5. Labeling of the glutamate receptor complex may allow in vivo diagnosis by positron emission tomography. 6. Glutamate receptor ligands may provide a means of therapeutic intervention in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900537     DOI: 10.1016/0278-5846(88)90102-9

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  36 in total

1.  Neuroprotective potential of ionotropic glutamate receptor antagonists.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

2.  Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients.

Authors:  Gulnur Sh Burbaeva; Irina S Boksha; Elena B Tereshkina; Olga K Savushkina; Lubov' I Starodubtseva; Marina S Turishcheva
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

3.  Pharmacotherapy in the treatment of Alzheimer's disease: an update.

Authors:  Brian E Leonard
Journal:  World Psychiatry       Date:  2004-06       Impact factor: 49.548

4.  Neurotoxic acylpolyamines from spider venoms.

Authors:  K D McCormick; J Meinwald
Journal:  J Chem Ecol       Date:  1993-10       Impact factor: 2.626

5.  Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction.

Authors:  Anna Kiryk; Tomomi Aida; Kohichi Tanaka; Pradeep Banerjee; Grzegorz M Wilczynski; Ksenia Meyza; Ewelina Knapska; Robert K Filipkowski; Leszek Kaczmarek; Wojciech Danysz
Journal:  Neurotox Res       Date:  2008-01       Impact factor: 3.911

Review 6.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

7.  Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid.

Authors:  Epolia Ramadan; Angelo O Rosa; Lisa Chang; Mei Chen; Stanley I Rapoport; Mireille Basselin
Journal:  J Lipid Res       Date:  2010-04-13       Impact factor: 5.922

8.  Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans.

Authors:  T H Rammsayer
Journal:  Learn Mem       Date:  2001 Jan-Feb       Impact factor: 2.460

Review 9.  The role of the N-methyl-D-aspartate receptor in Alzheimer's disease: therapeutic potential.

Authors:  P Murali Doraiswamy
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

Review 10.  Antioxidant treatment in Alzheimer's disease: current state.

Authors:  Yossi Gilgun-Sherki; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.